AIELLO, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 313
EU - Europa 160
AS - Asia 37
Totale 510
Nazione #
US - Stati Uniti d'America 313
UA - Ucraina 43
IT - Italia 40
FI - Finlandia 26
CN - Cina 23
DE - Germania 13
GB - Regno Unito 10
IE - Irlanda 10
SE - Svezia 9
SG - Singapore 8
RU - Federazione Russa 3
FR - Francia 2
IN - India 2
KR - Corea 2
BE - Belgio 1
CH - Svizzera 1
IR - Iran 1
PL - Polonia 1
RO - Romania 1
TR - Turchia 1
Totale 510
Città #
Ann Arbor 44
Des Moines 34
Ashburn 32
Chandler 24
Jacksonville 24
Fairfield 21
Houston 20
Palermo 20
Woodbridge 15
Wilmington 11
Dublin 10
Medford 8
Seattle 8
Cambridge 7
Singapore 7
Nanjing 6
Princeton 6
Tulsa 6
Boardman 5
New York 4
Shenyang 4
Auburn Hills 3
Altamura 2
Changsha 2
Dearborn 2
Jiaxing 2
Ningbo 2
Prineville 2
Seongnam 2
Beijing 1
Brussels 1
Dallas 1
Durham 1
Fuzhou 1
Hangzhou 1
Izmir 1
Jinan 1
Lanzhou 1
Lawrence 1
Ludwigshafen am Rhein 1
Milan 1
Moscow 1
Orange 1
Pune 1
Tehran 1
Tianjin 1
Trapani 1
Totale 351
Nome #
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. 196
FLUORINATED 2-PHENYLBENZOXAZOLES AS POTENT AND SELECTIVE ANTITUMOUR AGENTS. 88
Sintesi e studi QSAR di nuovi derivati 3(5)-(2-X)-1R-1H-4-nitrosopirazoli: una classe di composti con potente attività antifungina in vitro. 68
Synthesis and Antimicrobial Activity of New 1,5-Dimethyl-3-Heteroaryl.1H-4-ONN-Azoxycyanides 63
4-Nitrosopyrazole Derivatives as a New Class of Compounds with Potent in vitro Antifungal Activity 50
Sinthesys and Antifungal Activity of New 3(5)-methyl-5(3)-(2-thiophenyl and 2-furanyl)-1H-1-R-4-cyanopyrazoles 48
Totale 513
Categoria #
all - tutte 1.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 8 5 10 16 10 5 13 3 5 8
2020/202162 2 7 0 9 6 0 7 3 10 3 7 8
2021/202257 1 17 0 2 3 0 2 4 8 9 2 9
2022/202385 8 5 0 5 12 16 30 3 2 0 4 0
2023/202444 2 8 0 4 1 6 1 15 0 0 0 7
2024/20254 1 3 0 0 0 0 0 0 0 0 0 0
Totale 513